Diligence that reads the data, not the deck
I read an asset against the published record and hand back a verdict with every figure traced to its source. No invented metrics, no inflated claims. The work shows its receipts; you check them.
Verified Read
$5,000
One asset, fixed scope
~10 business days
I read your asset against the FDA filings, published trials, and peer-reviewed papers. Every claim traced to its source. You get a verdict you can act on, not a pile of pages.
Bespoke Diligence
from $10,000
Scoped to your thesis
Deal-grade depth
A mechanism audit. A read on an upcoming readout. A regulatory package. A data-room readout. Deep work, scoped to the decision you're making. Price depends on scope; quoted after our call.
How it works
The verdict
I read your asset and write a verdict: does the published data back the story, or are there gaps the deck glosses over? Every figure in the verdict is two clicks from its source -- FDA label, trial registry, published paper, SEC filing.
The turnaround
Verified Read: ~10 business days from payment and asset submission. Bespoke work depends on scope -- typically 2-4 weeks for mechanism audits and reads on upcoming readouts, longer for deep regulatory packages.
The scope
Verified Read is fixed: one asset, one read, one verdict. Bespoke diligence is scoped in a call -- mechanism audit, a read on an upcoming readout, regulatory narrative, data-room analysis, or a combination. Depth is named honestly; a fast pass over 20,000 pages is not the same as a deep read over weeks.
What this is not
This is verification against the published record, not legal advice, not investment advice, not a recommendation to buy or sell. It's decision input: the facts the read surfaces, not the decision itself. That's yours to make.
Questions?
Email chris@bigbio.ai with any questions about scope, timeline, or how the work is done.
or email me directly:chris@bigbio.ai